Hepatocellular carcinoma tumour burden score to stratify prognosis after resection

被引:104
|
作者
Tsilimigras, D. I. [1 ]
Moris, D. [1 ]
Hyer, J. M. [1 ]
Bagante, F. [1 ,4 ]
Sahara, K. [1 ]
Moro, A. [1 ]
Paredes, A. Z. [1 ]
Mehta, R. [1 ]
Ratti, F. [5 ]
Marques, H. P. [6 ]
Silva, S. [6 ]
Soubrane, O. [7 ]
Lam, V. [8 ]
Poultsides, G. A. [3 ]
Popescu, I. [10 ]
Alexandrescu, S. [10 ]
Martel, G. [11 ]
Workneh, A. [11 ]
Guglielmi, A. [4 ]
Hugh, T. [9 ]
Aldrighetti, L. [5 ]
Endo, I. [12 ]
Sasaki, K. [2 ]
Rodarte, A. [2 ]
Aucejo, F. N. [2 ]
Pawlik, T. M. [1 ]
机构
[1] Ohio State Univ, Dept Surg, Wexner Med Ctr, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
[2] Cleveland Clin, Digest Dis Inst, Cleveland, OH 44106 USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Univ Verona, Dept Surg, Verona, Italy
[5] Osped San Raffaele, Milan, Italy
[6] Curry Cabral Hosp, Dept Surg, Lisbon, Portugal
[7] Beaujon Hosp, AP HP, Dept Hepatobiliopancreat Surg, Clichy, France
[8] Westmead Hosp, Dept Surg, Sydney, NSW, Australia
[9] Univ Sydney, Sch Med, Sydney, NSW, Australia
[10] Fundeni Clin Inst, Dept Surg, Bucharest, Romania
[11] Univ Ottawa, Dept Surg, Ottawa, ON, Canada
[12] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
关键词
SURGICAL RESECTION; LIVER RESECTION; GUIDELINES; SURVIVAL; SELECTION; INVASION; SURGERY; SIZE; TOOL; HCC;
D O I
10.1002/bjs.11464
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system has been largely adopted in clinical practice, recent studies have emphasized the need for further refinement and subclassification of this system. Methods Patients who underwent hepatectomy with curative intent for BCLC-0, -A or -B hepatocellular carcinoma (HCC) between 2000 and 2017 were identified using a multi-institutional database. The tumour burden score (TBS) was calculated, and overall survival (OS) was examined in relation to TBS and BCLC stage. Results Among 1053 patients, 63 (6 center dot 0 per cent) had BCLC-0, 826 (78 center dot 4 per cent) BCLC-A and 164 (15 center dot 6 per cent) had BCLC-B HCC. OS worsened incrementally with higher TBS (5-year OS 77 center dot 9, 61 and 39 per cent for low, medium and high TBS respectively; P < 0 center dot 001). No differences in OS were noted among patients with similar TBS, irrespective of BCLC stage (61 center dot 6 versus 58 center dot 9 per cent for BCLC-A/medium TBS versus BCLC-B/medium TBS, P = 0 center dot 930; 45 versus 13 per cent for BCLC-A/high TBS versus BCLC-B/high TBS, P = 0 center dot 175). Patients with BCLC-B HCC and a medium TBS had better OS than those with BCLC-A disease and a high TBS (58 center dot 9 versus 45 per cent; P = 0 center dot 005). On multivariable analysis, TBS remained associated with OS among patients with BCLC-A (medium TBS: hazard ratio (HR) 2 center dot 07, 95 per cent c.i. 1 center dot 42 to 3 center dot 02, P < 0 center dot 001; high TBS: HR 4 center dot 05, 2 center dot 40 to 6 center dot 82, P < 0 center dot 001) and BCLC-B (high TBS: HR 3 center dot 85, 2 center dot 03 to 7 center dot 30; P < 0 center dot 001) HCC. TBS could also stratify prognosis among patients in an external validation cohort (5-year OS 79, 51 center dot 2 and 28 per cent for low, medium and high TBS respectively; P = 0 center dot 010). Conclusion The prognosis of patients with HCC varied according to the BCLC stage but was largely dependent on the TBS.
引用
收藏
页码:854 / 864
页数:11
相关论文
共 50 条
  • [1] HEPATOCELLULAR CARCINOMA TUMOR BURDEN SCORE TO STRATIFY PROGNOSIS AFTER LIVER TRANSPLANTATION.
    Moris, Dimitrios
    Shaw, Brian
    McElroy, Lisa M.
    Barbas, Andrew S.
    HEPATOLOGY, 2020, 72 : 809A - 809A
  • [2] Using Hepatocellular Carcinoma Tumor Burden Score to Stratify Prognosis after Liver Transplantation
    Moris, Dimitrios
    Shaw, Brian, I
    McElroy, Lisa
    Barbas, Andrew S.
    CANCERS, 2020, 12 (11) : 1 - 9
  • [3] Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker?
    Huo, Teh-Ia
    Liu, Po-Hong
    Hsu, Chia-Yang
    BRITISH JOURNAL OF SURGERY, 2020, 107 (12) : E625 - E625
  • [4] Preoperative Controlling Nutritional Status plus Tumor Burden Score for the Assessment of Prognosis after Curative Liver Resection for Hepatocellular Carcinoma
    Fukami, Yasuyuki
    Saito, Takuya
    Osawa, Takaaki
    Arikawa, Takashi
    Matsumura, Tatsuki
    Kurahashi, Shintaro
    Komatsu, Shunichiro
    Kaneko, Kenitiro
    Sano, Tsuyoshi
    MEDICAL PRINCIPLES AND PRACTICE, 2021, 30 (02) : 131 - 137
  • [5] The impact of tumor burden score on prognosis in patients after radical resection of hepatocellular carcinoma: a single-center retrospective study
    Huang, Junzhang
    Zhou, Ying
    Wei, Suosu
    Tang, Yuntian
    Zhang, Qiuhuan
    Tang, Yi
    Huang, Wei
    Mo, Chongde
    Dong, Xiaofeng
    Yang, Jianrong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score
    Wen He Zhao Zhi-Min Ma Xing-Ren Zhou Yi-Zheng Feng Bao-Shan Fang
    World Journal of Gastroenterology, 2002, 8 (02) : 237 - 242
  • [7] Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score
    Zhao, WH
    Ma, ZM
    Zhou, XR
    Feng, YZ
    Fang, BS
    WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (02) : 237 - 242
  • [8] Tumor burden score combined with AFP and PIVKA-II (TAP score) to predict the prognosis of hepatocellular carcinoma patients after radical liver resection
    Qiu, Zhan-Cheng
    Wu, You-Wei
    Dai, Jun-Long
    Qi, Wei-Li
    Chen, Chu-Wen
    Xu, Yue-Qing
    Shen, Jun-Yi
    Li, Chuan
    Wen, Tian-Fu
    LANGENBECKS ARCHIVES OF SURGERY, 2025, 410 (01)
  • [9] An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection
    Jin, Ye
    Liang, Zhi-Yong
    Zhou, Wei-Xun
    Zhou, Li
    FUTURE ONCOLOGY, 2022, 18 (26) : 2903 - 2917
  • [10] Prognosis of early hepatocellular carcinoma after hepatic resection
    Maeda, Takashi
    Shimada, Mitsuo
    Harimoto, Norifumi
    Tsujita, Eiji
    Aishima, Shin-ichi
    Tanaka, Shinji
    Shirabe, Ken
    Maehara, Yoshihiko
    HEPATO-GASTROENTEROLOGY, 2008, 55 (85) : 1428 - 1432